Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reno-Defend 1
2008-003786-20Phase 2Terminated
- Sponsor
- Solvay
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of derenofylline in heart failure (HF) (5 arms), sponsored by Solvay. Primary endpoints: Change in serum creatinine from Baseline to Day 14 and Trichotomous clinical outcome at Day 14. Started Dec 2008; status: terminated.
02
Drugs
derenofylline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-003786-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003786-20.